Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, today announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company ...

U.S. President Donald Trump's sweeping reciprocal tariffs sent shockwaves across key industries this week, with Wall Street ...